There was a recent webcast on the IAS USA website discussing the role of Maraviroc in PLWH and KS. Seems that CCR5 has some pathophysiologic ...
I have an independent private practice. We have an employee who wrangles our long acting antivirals - prior auth, scheduling, ...
Looking to re-open this conversation as my clinic has had 2 separate patients in 2 weeks time that have leaked after initial abdominal ...
Dear Colleagues, Our interdisciplinary team received funding from the National Institutes of Health (NIH) to study a pilot ...
Adam, Agree, thank you! My patient found a way to get injectable semaglutide covered, so we are going to stay with that for ...
Joel, Thank you for the reply. I had very similar thoughts! I offered to my patient the option of switching to Biktarvy. My ...
Apologies, I imagine this talk may have passed. I wanted to share a video of a related talk I might add. I didn't include the ...
Hi Ryan, In terms of absorption concerns with GLP1 RAs, I don't think there will be much of a difference in terms of changes ...
No personal experience. According to Liverpool, most prudent would be separate by 4 hours. If impossible, would monitor.
There is a theoretical risk with oral semaglutide, since it can lower gastric acid secretion, which could potentially interfere ...
Either the content you're seeking doesn't exist or it requires proper authentication before viewing.
Academy National Office1120 Connecticut Ave NW | Suite 423Washington, D.C. 20036
Phone: 202-659-0699Fax: 202-659-0976
JoinBenefitsLearn More
About UsTerms of UsePrivacy Policy Policy on Managing Conflicts of Interest